which is on track to earn around $100 million in annual sales. The companies currently split profits. While Sage is in a vulnerable spot, the company’s board argues Biogen’s offer “is not in ...
Jan 10 (Reuters) - Drugmaker Biogen (BIIB.O), opens new tab will buy all outstanding shares of Sage Therapeutics (SAGE.O), opens new tab that it does not already own for $7.22 apiece, a filing ...
Choosing the right accounting software is crucial for any business. With limited resources and staff, entrepreneurs need startup accounting systems that are affordable, easy to use, and provide the ...